Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Sales of Investments
Cash received from selling or redeeming investments.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Sales of Investments · Q2 FY2026 · quarter ended Jun 2026
Sales of investments dips below year-ago levels
Q2 FY2026 sales of investments of $96.18M fell 36.8% year over year, behind the +12.2% change in trailing-twelve-month sales of investments. Sequentially, it fell 30.2% from the prior quarter. Over 3 fiscal years it compounded at +599.5% a year.
Context
- Sales of investments amounted to 80.1% of revenue in FY2025, up 27.5 pp from a year earlier.
- Sales of investments increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -36.8% toward the trailing-twelve-month pace of +12.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 683.11M USD
- Year-over-year change
- +227.4%
- 3-year CAGR
- +599.5%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 683.11M | +227.4% |
| FY2024 | 2024-12-31 | 208.67M | +87.6% |
| FY2023 | 2023-12-31 | 111.21M | +5471.8% |
| FY2022 | 2022-12-31 | 2M | — |
Sales of Investments vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's LTM Jun 2026 sales of investments of $573.44M is the 3rd largest of the 7 companies compared; the peer median is $130.01M.
- Its year-over-year change of +12.2% is the 2nd highest of 4, against a peer median of -11.8%.
- Sales of investments amounts to 47.7% of revenue for ALAB, versus a peer median of 3.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $4.52B | -42.9% | -21.4% | 21.8% | |
| LTM Aug 2026 | $990.66M | +165.7% | — | 7.1% | |
| LTM Jun 2026 | $573.44M | +12.2% | +599.5% | 47.7% | |
| LTM Aug 2026 | $260.01M | -11.8% | +83.7% | 16.3% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ALAB) | $130.01M | -11.8% | +31.2% | 3.6% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Net Income | (58.35M) | (26.26M) | (83.42M) | 219.13M |
| Depreciation & Amortization | 807K | 1.78M | 3.15M | 6.83M |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 30.24M | 10.68M | 234.59M | 160.03M |
| Change in Working Capital | (9.97M) | (9.68M) | (13.3M) | (65.96M) |
| Accounts Receivables | (6.04M) | 2.39M | (30.48M) | (44.34M) |
| Inventory | (19.36M) | (5.56M) | (19.29M) | (12.95M) |
| Accounts Payables | 2.13M | (4.26M) | 20.89M | 14.19M |
| Other Working Capital | 13.3M | (2.23M) | 15.59M | (22.87M) |
| Other Non-Cash Items | 1.38M | 10.76M | (4.35M) | (726K) |
| Operating Cash Flow | (35.9M) | (12.72M) | 136.68M | 319.31M |
| Capital Expenditures | (3.87M) | (2.76M) | (34.25M) | (37.54M) |
| Acquisitions (Net) | 0 | 0 | 0 | (28.79M) |
| Purchases of Investments | (88.71M) | (126.23M) | (930.58M) | (857.75M) |
| Sales of Investments | 2M | 111.21M | 208.67M | 683.11M |
| Other Investing Activities | 0 | 0 | (1.41M) | (500K) |
| Investing Cash Flow | (90.59M) | (17.77M) | (757.57M) | (241.47M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 672.2M | 9.8M |
| Common Stock Repurchased | (313K) | (210K) | (1.07M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.12M | (292K) | (15.29M) | 0 |
| Financing Cash Flow | 151.67M | (502K) | 655.84M | 9.8M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | 25.18M | (30.99M) | 34.95M | 87.64M |
| Free Cash Flow | (39.77M) | (15.48M) | 102.43M | 281.76M |
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.